IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+17.81%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$200M
AUM Growth
+$200M
(-17%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-33.93%
Top 10 Holdings %
Top 10 Hldgs %
50.04%
Holding
142
New
18
Increased
7
Reduced
40
Closed
52
Top Buys
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$12.7M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$11.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$11.3M |
| 4 |
United Therapeutics
UTHR
|
$9.43M |
| 5 |
Celldex Therapeutics
CLDX
|
$6.2M |
Sector Composition
| 1 | Healthcare | 98.33% |
| 2 | Consumer Staples | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
26
DELISTED
bluebird bio
BLUE
| $2.93M | 0.58% |
+462,628
| New | +$2.93M |
|
27
Biogen
BIIB
$19.4B
| $2.93M | 0.58% |
10,962
+9,840
| +877% | +$2.63M |
|
|
RVNC
28
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.7M | 0.54% |
+100,000
| New | +$2.7M |
|
29
Cogent Biosciences
COGT
$1.69B
| $2.43M | 0.48% |
162,766
-87,234
| -35% | -$1.3M |
|
30
Sarepta Therapeutics
SRPT
$1.78B
| $1.86M | 0.37% |
16,809
-8,191
| -33% | -$905K |
|
31
Lyra Therapeutics
LYRA
$11.5M
| $1.72M | 0.34% |
343,685
-3,653
| -1% | -$18.3K |
|
|
CINC
32
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $1.48M | 0.3% |
+45,100
| New | +$1.48M |
|
33
Viking Therapeutics
VKTX
$3.04B
| $1.26M | 0.25% |
463,156
-372,119
| -45% | -$1.01M |
|
|
ICPT
34
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.19M | 0.24% |
85,200
-19,800
| -19% | -$276K |
|
35
89bio
ETNB
$1.34B
| $1.16M | 0.23% |
+200,000
| New | +$1.16M |
|
36
Ocular Therapeutix
OCUL
$2.12B
| $1.1M | 0.22% |
+265,000
| New | +$1.1M |
|
37
X4 Pharmaceuticals
XFOR
$84.2M
| $973K | 0.19% |
568,612
-1,111,136
| -66% | -$1.9M |
|
38
Seres Therapeutics
MCRB
$166M
| $843K | 0.17% |
131,310
-409,314
| -76% | -$2.63M |
|
|
BCLI
39
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $839K | 0.17% |
189,935
-63,497
| -25% | -$280K |
|
|
STSA
40
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $815K | 0.16% |
136,059
-517,389
| -79% | -$3.1M |
|
|
RCOR
41
DELISTED
Renovacor, Inc.
RCOR
| $725K | 0.14% |
288,119
-5,164
| -2% | -$13K |
|
42
Eledon Pharmaceuticals
ELDN
$155M
| $612K | 0.12% |
221,830
-140,707
| -39% | -$388K |
|
|
CMMB
43
Chemomab Therapeutics
CMMB
$16.3M
| $612K | 0.12% |
245,896
-22,208
| -8% | -$55.3K |
|
|
44
Alnylam Pharmaceuticals
ALNY
$58.5B
| $560K | 0.11% |
2,800
-58,437
| -95% | -$11.7M |
|
45
Protara Therapeutics
TARA
$120M
| $558K | 0.11% |
188,664
-69,189
| -27% | -$205K |
|
|
AUTL
46
Autolus Therapeutics
AUTL
$399M
| $556K | 0.11% |
260,087
-62,130
| -19% | -$133K |
|
|
BLCM
47
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $537K | 0.11% |
448,101
-75,247
| -14% | -$90.2K |
|
|
OKUR
48
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $521K | 0.1% |
155,819
-29,778
| -16% | -$99.6K |
|
49
Immatics
IMTX
$619M
| $490K | 0.1% |
49,031
-108,159
| -69% | -$1.08M |
|
50
Anebulo Pharmaceuticals
ANEB
$103M
| $437K | 0.09% |
156,203
-24,996
| -14% | -$69.9K |
|